1 Ghafourian T, Barzegar-Jalali M, Hakimiha N, Cronin MT. Quantitative structure-pharmacokinetic relationship modelling : Apparent volume of distribution[J].J Pharm Pharmacol, 2004;56(3):339-50
2 Turner JV, Maddalena DJ, Agatonovic-Kustrin S. Bioavailability prediction based on molecular structure for a diverse series of drugs[J].Pharm Res, 2004;21(1):68-82
3 Turner JV, Maddalena DJ, Cutler DJ.Pharmacokinetic parameter prediction from drug structure using artificial neural networks[J].Int J Pharm, 2004;270(2):209-19
4 Regardh C G, Edgar B, Olsson R, Kendall M, Collste P, Shansky C.Pharmacokinetics of felodipine in patients with liver disease[J].Eur J Clin Pharmacol, 1989;36(5):473-9
5 Fujimura A, Ohashi K, Sugimoto K, Kumagai Y, Ebihara A. Chronopharmacological study of nitrendipine in healthy subjects[J].J Clin Pharmacol, 1989;29(10):909-15
6 Guerret M, Cheymol G, Hubert M, Julien-Larose C, Lavene D.Simultaneous study of the pharmacokinetics of intravenous and oral nicardipine using a stable isotope[J].Eur J Clin Pharmacol, 1989;37(4):381-5
7 Chen DG, Feng QP, Wang ZQ, Chen K.Pharmacodynamics and pharmacokinetics of nifedipine in patients with congestive heart failure[J].Acta Pharmacol Sin, 1989;10(3):233-8
8 Pasanisi F, Meredith PA, Reid JL.The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects[J].Eur J Clin Pharmacol, 1985;29(1):21-4
9 Shenfield GM, Boutagy J, Stokes GS, Rumble F, Dunagan F. The pharmokinetics of isradipine in hypertensive subjects[J]. Eur J Clin Pharmacol, 1990;38(2):209-11
10 Boelaert J, Valcke Y, Dammekens H, De Vriese G, Ahr G, SchurgersM, et al.Pharmacokinetics of nisoldipine in renal dysfunction[J].Eur J Clin Pharmacol, 1988;34(2):207-9
11 Kobayashi H, Kobayashi S, Dalrymple PD, Wood SG, Chasseaud LF.Absorption, metabolism and excretion after oral administration of a new Ca antagonist, 14C-benidipine hydrochloride to man[J].Xenobiotica, 1997;27(6):597-608
12 Inoue Y, Nakayama K, Wachi M, Kumakura K, Matsumoto T, Iwamoto M, et al.Absorption, distribution, metabolism and excretion of 2, 6-dimethyl-3, 5-dimethoxycarbony l-4-(o-difluoromethoxyphenyl)-1, 4-dihydropyridine (PP-1466) in rat[J].Arzneimittelforschung, 1985;35(5):813-8
13 Sannita WG, Busico S, Di Bon G, Ferrari A, Riela S.Pharmacokinetics and electro-encephalographic effects of darodipine 50-200 mg modified release (MR) acute oral administration: dose-finding study in healthy volunteers[J].Int J Clin Pharmacol Res, 1993;13(5):281-91
14 Rosillon D, Stockis A, Poli G, Acerbi D, Lins R, Jeanbaptiste B.Food effect on the oral bioavailability of manidipine : single dose, randomized, crossover study in healthy male subjects[J].Eur J Drug Metab Pharmacokinet, 1998;23(2):197-202
15 Seydel JK, Schaper KJ.Quantitative structure-pharmacokineticrelationships and drug design[J].Opharmacol Ther, 1982;15(2):131-82
16 Fleisher D, Li C, Zhou Y, Pao LH, Karim A.Drug, meal and formulation interactions influencing drug absorption after oral administration[J].Clin Pharmacokinet, 1999;36(3):233-54 |
